Inhibitors of histone deacetylase are potentially effective anticancer agents Journal Article


Authors: Marks, P. A.; Rifkind, R. A.; Richon, V. M.; Breslow, R.
Article Title: Inhibitors of histone deacetylase are potentially effective anticancer agents
Keywords: cancer chemotherapy; leukemia; unclassified drug; human cell; histone deacetylase inhibitor; clinical trial; drug efficacy; nonhuman; antineoplastic agents; mouse; animal tissue; melanoma; ovary cancer; lung cancer; editorial; antineoplastic activity; drug effect; tumor cells, cultured; breast neoplasms; cancer model; prostate cancer; cancer inhibition; neuroblastoma; enzyme inhibitors; colon cancer; cancer cell; vorinostat; hydroxamic acids; dye; histone deacetylases; hydroxamic acid; butyric acid; trichostatin a; benzamide derivative; fr 901228; oxamflatin; pyroxamide; apicidin; cancer; humans; human; female; priority journal; ms 27275
Journal Title: Clinical Cancer Research
Volume: 7
Issue: 4
ISSN: 1078-0432
Publisher: American Association for Cancer Research  
Date Published: 2001-04-01
Start Page: 759
End Page: 760
Language: English
PUBMED: 11309319
PROVIDER: scopus
DOI/URL:
Notes: Export Date: 21 May 2015 -- Source: Scopus
Citation Impact
MSK Authors
  1. Victoria M Richon
    91 Richon
  2. Paul Marks
    186 Marks
  3. Richard Rifkind
    118 Rifkind